Freedom Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Freedom Investment Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,839	Closed	-$439K	–	895
2015 Q4	$439K	Sell	2,839 -195,931	-99%	-$28.6M	0.03%	439
2015 Q3	$2.11M	Buy	198,770 +196,520	+8,734%	+$27.5M	0.22%	56
2015 Q2	$323K	Sell	2,250 -267	-11%	-$38.1K	0.03%	465
2015 Q1	$355K	Sell	2,517 -9	-0.4%	-$1.39K	0.04%	423
2014 Q4	$374K	Sell	2,526 -2,592	-51%	-$381K	0.05%	351
2014 Q3	$787K	Buy	5,118 +2,670	+109%	+$402K	0.14%	134
2014 Q2	$343K	Buy	+2,448	New	+$272K	0.06%	305

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Freedom Investment Management's TARO Position: Q1 2016 in Review

Freedom Investment Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2016, closing a stake of 2,839 shares — an estimated $439K sold.

Freedom Investment Management first reported a position in TARO in Q2 2014 and held it in 7 quarters. The position peaked at $2.11M in Q3 2015. 167 funds tracked by Wall St. Rank hold TARO as of Q1 2016.

Freedom Investment Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2016 after selling out during the quarter.
Freedom Investment Management sold 2,839 Taro Pharmaceutical Industries Ltd. shares in Q1 2016, an estimated $439K.
Freedom Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 7 quarters.
Freedom Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $2.11M in Q3 2015.
167 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2016.

Based on Freedom Investment Management's 13F filing for Q1 2016, filed 8 Apr 2016.